Omeros (OMER)

Latest Trade: $5.82 0.00 (0.0%)

IPO News

Omeros quiet period ends November 16 11/11/09
Verisk is this week's IPO winner 10/9/09
Mistras Group and Omeros are today's IPOs 10/8/09
Seattle-based biotech Omeros prices IPO at $10.00, at low end of the range 10/8/09
Upcoming IPOs: Banco Santander Br, Mistras Group, and more 10/4/09
IPO market continues pick-up 10/2/09
Seattle-based biotech Omeros sets IPO terms 9/16/09
Biopharmaceutical company Omeros files for an IPO 1/9/08

Latest User Comments

Post Comment | Read More

Business

Business
Developing drugs for the treatment of surgery-related inflammation and pain.
Industry
Health-Drugs
Employees
62
Founded
1994

Performance History

Invest in the IPO Plus Fund

First Day Return
8.7300

-12.7%
Aftermarket Return
8.7300

-33.3%
Return from IPO
10.0000

-41.8%

IPO Date
10/07/09
Offer Price
$10.00
Offer Shares
6.8 mm
Lead Manager(s)
Deutsche Bank
Co Manager(s)
Wedbush PacGrow

All Underwriters

OMER Daily

Week

Month

Quarter

1 Year

Basic
Comps

Financial Data* ($ in millions)

Market Cap
$123.9
Revenues
$1
Net Income
($25)
*Revenues and Net Income are for last twelve months ending 06/30/09
View Prospectus and other SEC Filings

Corporate Data

Company Address
1240 Fifth Avenue, Suite 2600
Seattle, WA
Phone Number
206-676-5000
Web Address
www.omeros.com